Press Releases

Latest Press Releases

Cyteir Therapeutics Presents Preclinical Data on Use of DNA Repair Modulators for Lymphoid Malignancies at American Society of Hematology Annual Meeting

cyteir 2018-03-07T22:47:27+00:00 November 29th, 2016|

Cyteir Therapeutics Presents Preclinical Data on Use of DNA Repair Modulators for Lymphoid Malignancies at American Society of Hematology Annual Meeting -- Preclinical data elucidates mechanism of cell death response to selectively target lymphoid cancers [...]

Cyteir Therapeutics Receives $2M Grant from National Cancer Institute

cyteir 2018-03-07T22:48:24+00:00 June 29th, 2016|

Cyteir Therapeutics Receives $2M Grant from National Cancer Institute CAMBRIDGE, Mass. – June 29, 2016 – Cyteir Therapeutics, Inc., a leader in the development of novel therapeutics based on the biology of DNA repair, today announced [...]

Jackson Laboratory Spinout Cyteir Therapeutics Inc. Announces $5.5 Million Series A Financing and Appointment of Donald F. Corcoran as President and Chief Executive Officer

cyteir 2018-03-07T22:48:59+00:00 November 5th, 2015|

Jackson Laboratory Spinout Cyteir Therapeutics Inc. Announces $5.5 Million Series A Financing and Appointment of Donald F. Corcoran as President and Chief Executive Officer Proceeds will provide funding to Cyteir Therapeutics to advance its [...]